| Date Filed | Type | Description |
| 02/01/2019 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 06/28/2018 |
GN
| Multi-Center Market Research Confirms Nasal Valve Collapse as a Contributor for Most Nasal Obstruction Sufferers |
| 06/19/2018 |
GN
| Entellus Medical announces publication of the 1-year results of a randomized controlled trial comparing balloon dilation with medical therapy for treatment of persistent Eustachian tube dysfunction |
| 03/12/2018 |
15-12B
| Form 15-12B - Securities registration termination [Section 12(b)]: |
| 03/08/2018 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 03/07/2018 |
SC 13D/A
| Split Rock Partners, LP reports a 0% stake in ENTELLUS MEDICAL, INC. |
| 03/07/2018 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 03/07/2018 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 03/02/2018 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 02/28/2018 |
SC 13D
| STRYKER CORP reports a 100% stake in ENTELLUS MEDICAL, INC. |
| 02/28/2018 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 02/28/2018 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 02/28/2018 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 02/28/2018 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 02/28/2018 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 02/28/2018 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities: |
| 02/28/2018 |
8-K
| Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Fa... |
| 02/26/2018 |
8-K
| Submission of Matters to a Vote of Security Holders |
| 02/15/2018 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 01/24/2018 |
DEFM14A
| Form DEFM14A - Definitive proxy statement relating to merger or acquisition: |
| 01/08/2018 |
PREM14A
| Form PREM14A - Preliminary proxy statements relating to merger or acquisition: |
| 01/04/2018 |
8-K
| Quarterly results |
| 01/04/2018 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 12/29/2017 |
SC 13D
| Sand Grove Capital Management LLP reports a 5.2% stake in ENTELLUS MED INC |
| 12/18/2017 |
SC 13D
| STRYKER CORP reports a 35.9% stake in ENTELLUS MEDICAL, INC. |
| 12/11/2017 |
SC 13D/A
| SVLSF IV, LLC reports a 7.2% stake in ENTELLUS MEDICAL, INC. |
| 12/11/2017 |
SC 13D/A
| KKR Fund Holdings L.P. reports a 5.5% stake in ENTELLUS MEDICAL, INC. |
| 12/11/2017 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 12/08/2017 |
SC 13D/A
| Discovery Group I, LLC reports a 0% stake in Entellus Medical, Inc. |
| 12/07/2017 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 12/07/2017 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 12/07/2017 |
8-K
| Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits|
Docs:
|
"UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 of the Securities Exchange Act of 1934 Date of Report : December 7, 2017 ENTELLUS MEDICAL, INC. Delaware 001-36814 20-4627978 3600 Holly Lane North, Suite 40 Plymouth, Minnesota 55447 463-1595 Not Applicable Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act ☒ Soliciting material pursuant to Rule 14a-12 under the Exchange Act ☐ Pre-commencement communications pursuant to Rule 14d-2 under the Exchange Act ) ☐ Pre-commencement communications pursuant to R...",
"Agreement and Plan of Merger, by and among Stryker Corporation, Explorer Merger Sub Corp. and Entellus Medical, Inc. (filed herewith)",
"Form of Voting Agreement, by and between Stryker Corporation and the applicable stockholder of Entellus Medical, Inc. (filed herewith)",
"Contact: Lynn Pieper Lewis 415-937-5402 [email protected] Entellus Medical Announces Definitive Agreement to be Acquired by Stryker Corporation for a Purchase Price of $24.00 Per Share in Cash" |
|
| 12/07/2017 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 12/07/2017 |
GN
| Entellus Medical Announces Definitive Agreement to be Acquired by Stryker Corporation for a Purchase Price of $24.00 Per Share in Cash |
|